Markets.com Logo

AIMBU

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    18.2245$
  • Previous Close
    18.2245$
  • 52 Week Change
    9.39$
  • Day Range
    0.00$
  • 52 Week High/Low
    10.01$ - 19.4$
  • Dividend Per Share
    --
  • Market cap
    0$
  • EPS
    --
  • Beta
    -0.237
  • Volume
    --

About

AIMBU.US is a CUSIP for the AIM Ultra Short Bond ETF. It is an exchange-traded fund (ETF) that invests primarily in U.S. dollar-denominated investment-grade fixed-income securities with an average portfolio duration of one year or less. The fund seeks to provide current income while maintaining liquidity and preserving capital.
Weekly Forex Forecast: EUR/USD Eyes 1.16 Support as AUD/USD Rallies and USD/JPY Tests 160.00

Weekly Forex Forecast: EUR/USD Eyes 1.16 Support as AUD/USD Rallies and USD/JPY Tests 160.00

Ghko B|--
BTC price analysis: Bitcoin price (BTC/USD) is under $69K, what’s happening with Bitcoin?

BTC price analysis: Bitcoin price (BTC/USD) is under $69K, what’s happening with Bitcoin?

Frances Wang|--

Middle East Tensions Spark Rate Hike Speculation: Will the Fed Pivot from Easing?

Ava Grace|--

Geopolitical Energy Shocks Threaten AI Boom and Economic Growth

Emma Rose|--
US index analysis: Dow Jones Industrial Average dropped over 768 points, why is Dow falling?

US index analysis: Dow Jones Industrial Average dropped over 768 points, why is Dow falling?

Frances Wang|--
Trending gold stock analysis: JSE: ANG stock dropped today, what happened to AngloGold Ashanti PLC?

Trending gold stock analysis: JSE: ANG stock dropped today, what happened to AngloGold Ashanti PLC?

Frances Wang|--

The Hormuz Dilemma: Allies Face a Thorny Choice Over Oil Security and International Law

Noah Lee|--

Factors

Company Performance: AIM ImmunoTech's success in clinical trials for its drug Ampligen directly impacts the stock price.

Market Sentiment: Overall investor confidence and risk appetite affect demand for biotech stocks like AIMBU.US.

Regulatory Approvals: FDA decisions on Ampligen's approval are major price catalysts.

Competition: Competing therapies in the same disease areas influence AIMBU.US value.

Financial Health: AIM ImmunoTech's cash reserves, debt levels, and burn rate affect investor perception.

Partnerships: Collaborations with other companies can positively impact AIMBU.US stock.

People Also Watch

Latest news

Gold price today, March 23: Gold drops, XAU/USD price plunges below $4,278

Gold price today, March 23: Gold drops, XAU/USD price plunges below $4,278

Ghko B|--
BTC news today: Bitcoin keeps falling, what’s going on with bitcoin?

BTC news today: Bitcoin keeps falling, what’s going on with bitcoin?

Ghko B|--

Global Market Analysis: Geopolitical Tensions and Central Bank Shifts

Liam James|--

Latest Education Articles

NIO stock trading guide 2026: How to buy NIO stock from South Africa (ZA)?

NIO stock trading guide 2026: How to buy NIO stock from South Africa (ZA)?

Ghko B|--
Commodity CFDs explained: How to trade the price of gold (XAU) CFDs online in UAE?

Commodity CFDs explained: How to trade the price of gold (XAU) CFDs online in UAE?

Ghko B|--
Commodity Market Terms: What Are Basic Commdity Market Terms for Beginners in UAE?

Commodity Market Terms: What Are Basic Commdity Market Terms for Beginners in UAE?

Ghko B|--